MRSA is remarkably common. About 1 in 30 people carry the bacteria without any symptoms, and the United States sees an estimated 80,000 or more invasive MRSA infections each year. While hospital-acquired cases have dropped significantly over the past two decades, community-acquired infections have been climbing, making MRSA a concern well beyond hospital walls.
How Many People Carry MRSA
There’s an important distinction between carrying MRSA and having an active infection. Many people have MRSA living harmlessly in their nose or on their skin without ever getting sick. Among healthy adults, roughly 0.8% are asymptomatic MRSA carriers. The rate is higher in children: a global analysis of over 21,000 young children found that 3.4% carried MRSA in their upper respiratory tract with no symptoms. For context, about 25% of those same children carried regular staph bacteria, so MRSA represents a smaller but meaningful slice of overall staph colonization.
Carrier rates climb in specific settings. In elderly care facilities, the global MRSA colonization rate is about 15%, with facilities in the Americas averaging over 22%. U.S. nursing homes specifically report rates near 24%. These higher numbers reflect the combination of older immune systems, frequent antibiotic use, and close living quarters that give MRSA more opportunities to spread and persist.
Infection Rates in the United States
CDC surveillance from 2020, drawn from catchment areas covering about 15 million people, recorded 3,051 invasive MRSA cases and 493 deaths in those areas alone. Scaling to the national population puts the annual burden well into the tens of thousands of serious infections. The majority of these, roughly 77%, were healthcare-associated, meaning the person had recent contact with a hospital, dialysis center, nursing home, or similar facility. About 22% were purely community-acquired, occurring in people with no recent healthcare exposure.
Among the healthcare-associated cases, most didn’t actually start in the hospital. Around 80% were classified as “community-onset,” meaning the infection showed up after the patient had gone home but was linked to a recent healthcare encounter. This pattern matters because it means you can pick up MRSA during a hospital stay and not develop symptoms until days or weeks later.
Trends Over the Past Two Decades
The trajectory depends on which type of MRSA you’re looking at. Hospital-onset MRSA bloodstream infections dropped dramatically between 2005 and 2012, declining about 17% per year thanks to aggressive infection-control measures like better hand hygiene, screening programs, and changes in how catheters are managed. That decline slowed after 2012, settling to about a 7% annual decrease through 2017. By 2014 to 2019, the downward trend had essentially stalled.
Community-acquired MRSA moved in the opposite direction. Before the pandemic, these infections were increasing at roughly 8.4% per year. COVID-19 disrupted all these patterns: hospital-onset cases spiked in 2021, partly because 18% to 22% of those patients had recent COVID-19 infections, which may have made them more vulnerable. Community-acquired cases dipped during the pandemic years, likely because people had less close contact in gyms, sports, and other group settings. Whether those community rates have resumed their pre-pandemic climb is still being tracked.
Where MRSA Spreads Most Easily
MRSA thrives anywhere people share space, equipment, or skin-to-skin contact. Military training environments are a clear example. Studies of U.S. military trainees found that 4% to 6% developed skin and soft tissue infections during training, and when those infections were cultured, MRSA accounted for 70% of the staph isolates. That’s a strikingly high proportion, driven by shared barracks, physical contact during training, and minor skin abrasions that give bacteria an entry point.
Similar patterns show up in contact sports like wrestling and football, in prisons, and in homeless shelters. The common thread is skin contact, shared surfaces (towels, razors, workout equipment), and crowded conditions. You don’t need a weakened immune system to get infected in these settings. Healthy, young people make up a large share of community-acquired cases.
Global Prevalence
MRSA is not just an American problem, though rates vary widely by region. The Americas have the highest MRSA colonization rates overall, averaging around 22% in elderly care settings. Europe tends to be lower at about 11% on average, though individual countries vary. Poland’s rate (22%) is more than double the European average, while other Western European countries have kept rates relatively low through strict antibiotic stewardship programs. In the Western Pacific region, Singapore reports about 22% and China about 18%.
These regional differences largely reflect how antibiotics are prescribed and regulated. Countries with tighter controls on antibiotic use, particularly the Scandinavian nations and the Netherlands, consistently report lower MRSA rates. In countries where antibiotics are available over the counter or prescribed more liberally, resistant bacteria have more opportunities to develop and spread.
Skin Infections vs. Invasive Disease
Most MRSA infections are skin and soft tissue problems: boils, abscesses, and infected cuts that are painful and unpleasant but treatable. These are far more common than the invasive infections tracked by the CDC, which involve the bloodstream, lungs, surgical sites, or other internal organs. The vast majority of people who get MRSA will deal with a skin infection that can be drained and treated without hospitalization.
Invasive MRSA is a different story. The 2020 CDC surveillance data showed a case fatality rate of about 16% for all invasive MRSA infections. Hospital-onset cases were deadlier, with roughly 30% of patients dying, compared to about 12% for community-associated cases. The difference reflects the fact that hospital-onset infections tend to strike people who are already seriously ill, elderly, or immunocompromised. A young, otherwise healthy person who develops a MRSA skin boil after a gym session faces a very different risk profile than an ICU patient who develops MRSA in their bloodstream.
Who Faces the Highest Risk
Your risk of a serious MRSA infection depends heavily on your circumstances. The highest-risk groups include people with recent hospitalizations or surgeries, those on dialysis, residents of long-term care facilities, people with implanted medical devices like catheters or artificial joints, and anyone with a compromised immune system. Having a prior MRSA infection also significantly raises your odds of another one.
In community settings, risk factors look different. Athletes in contact sports, military recruits, people who are incarcerated, injection drug users, and people living in crowded conditions all face elevated risk. Children in daycare settings also pick up MRSA at higher rates than the general population, consistent with their higher carrier rates. Even without these risk factors, anyone can get a MRSA skin infection through a cut, scrape, or close contact with a carrier, though the odds of it progressing to something dangerous are low in otherwise healthy people.